Your browser doesn't support javascript.
loading
Development and preliminary validation of the challenges of living with cystic fibrosis (CLCF) questionnaire: a 46-item measure of treatment burden for parent/carers of children with CF.
Glasscoe, Claire; Hope, Holly F; Lancaster, Gillian A; McCray, Gareth; West, Kiri; Patel, Latifa; Patel, Tulsi; Hill, Jonathan; Quittner, Alexandra L; Southern, Kevin W.
Afiliação
  • Glasscoe C; Institute of Translational Medicine, Department of Women's & Children's Health, University of Liverpool, Liverpool, UK.
  • Hope HF; Division of Psychology & Mental Health, University of Manchester, Manchester, UK.
  • Lancaster GA; School of Medicine, Keele University, Keele, UK.
  • McCray G; School of Medicine, Keele University, Keele, UK.
  • West K; DMOPS (Movement Disorders), Liverpool University Hospitals NHS Foundation Trust (Aintree site), Liverpool, UK.
  • Patel L; Respiratory Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Patel T; Evelina London Children's Hospital, London, UK.
  • Hill J; School of Psychology & Clinical Language Sciences, University of Reading, Reading, UK.
  • Quittner AL; Children's Research Institute, Miami Children's Hospital, Miami, Florida, USA.
  • Southern KW; Institute of Translational Medicine, Department of Women's & Children's Health, University of Liverpool, Liverpool, UK.
Psychol Health ; 38(10): 1309-1344, 2023.
Article em En | MEDLINE | ID: mdl-35259034
ABSTRACT

OBJECTIVE:

Treatments for cystic fibrosis (CF) are complex, labour-intensive, and perceived as highly burdensome by caregivers of children with CF. An instrument assessing burden of care is needed.

DESIGN:

A stepwise, qualitative design was used to create the CLCF with caregiver focus groups, participant researchers, a multidisciplinary professional panel, and cognitive interviews. MAIN OUTCOME

MEASURES:

Preliminary psychometric analyses evaluated the reliability and convergent validity of the CLCF scores. Cronbach's alpha assessed internal consistency and t-tests examined test-retest reliability. Correlations measured convergence between the Treatment Burden scale of the Cystic Fibrosis Questionnaire-Revised (CFQ-R) and the CLCF. Discriminant validity was assessed by comparing CLCF scores in one vs two-parent families, across ages, and in children with vs without Pseudomonas aeruginosa (PA).

RESULTS:

Six Challenge subscales emerged from the qualitative data and the professional panel constructed a scoresheet estimating the Time and Effort required for treatments. Internal consistency and test-retest reliability were adequate. Good convergence was found between the Total Challenge score and Treatment Burden on the CFQ-R (r=-0.49, p = 0.02, n = 31). A recent PA infection signalled higher Total Challenge for caregivers (F(23)11.72, p = 0.002).

CONCLUSIONS:

The CLCF, developed in partnership with parents/caregivers and CF professionals, is a timely, disease-specific burden measure for clinical research.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article